Cross-institution positioning
Jul 28, 2026Accumulation leaning. 1 accumulating across 1 comparable institution.
Source: Schedule 13 researchESTABLISHMENT LABS HOLDINGS INC.
Latest stored close $60.61 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Accumulation leaning. 1 accumulating across 1 comparable institution.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/51 non-amendment material event in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +31.7% YoY; Net income +29.2% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 57% through its reported 52-week range; +94.0% over one year.
Source: Stored historical price seriesFiled Jul 28, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Custin Ann | AGrant, award, or other acquisition | Common Shares | 301 | $64.17 | Direct | Oct 2, 2026 |
| Sep 30, 2026 | Slotkin Bryan | AGrant, award, or other acquisition | Common Shares | 253 | $64.17 | Direct | Oct 2, 2026 |
| Sep 30, 2026 | LEWIN NICHOLAS SHERIDAN | AGrant, award, or other acquisition | Common Shares | 389 | $64.17 | Direct | Oct 2, 2026 |
| Sep 30, 2026 | SCHUTTER EDWARD J | AGrant, award, or other acquisition | Common Shares | 253 | $64.17 | Direct | Oct 2, 2026 |
| Sep 30, 2026 | Gillin Leslie | AGrant, award, or other acquisition | Common Shares | 262 | $64.17 | Direct | Oct 2, 2026 |
| Aug 20, 2026 | Caldini Filippo | FTax/price withholding or payment | Common Shares | 682 | $71.52 | Direct | Aug 26, 2026 |
| Jun 30, 2026 | Gillin Leslie | AGrant, award, or other acquisition | Common Shares | 196 | $85.81 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | Custin Ann | AGrant, award, or other acquisition | Common Shares | 239 | $85.81 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | LEWIN NICHOLAS SHERIDAN | AGrant, award, or other acquisition | Common Shares | 291 | $85.81 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | SCHUTTER EDWARD J | AGrant, award, or other acquisition | Common Shares | 216 | $85.81 | Direct | Jul 1, 2026 |
| Jun 30, 2026 | Slotkin Bryan | AGrant, award, or other acquisition | Common Shares | 189 | $85.81 | Direct | Jul 1, 2026 |
| Jun 24, 2026 | Harris Taylor C. | AGrant, award, or other acquisition · amendment | Common Shares | 1.8K | $0.00 | Direct | Jul 1, 2026 |
| Jun 24, 2026 | Harris Taylor C. | AGrant, award, or other acquisition · amendment | Common Shares | 1.9K | $0.00 | Direct | Jul 1, 2026 |
| Jun 24, 2026 | Harris Taylor C. | AGrant, award, or other acquisition | Common Shares | 1.3K | $0.00 | Direct | Jun 29, 2026 |
| Jun 24, 2026 | Harris Taylor C. | AGrant, award, or other acquisition | Common Shares | 1.9K | $0.00 | Direct | Jun 29, 2026 |
| May 28, 2026 | JW Asset Management, LLC, JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC, Wild Jason G. | SOpen-market or private sale | Common Shares | 65.1K | $72.89 | Indirect | May 28, 2026 |
| May 27, 2026 | JW Asset Management, LLC, JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC, Wild Jason G. | SOpen-market or private sale | Common Shares | 113 | $72.50 | Indirect | May 28, 2026 |
| May 26, 2026 | JW Asset Management, LLC, JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC, Wild Jason G. | SOpen-market or private sale | Common Shares | 25.3K | $74.39 | Indirect | May 28, 2026 |
| May 22, 2026 | Slotkin Bryan | AGrant, award, or other acquisition | Common Shares | 2.4K | $0.00 | Direct | May 26, 2026 |
| May 22, 2026 | SCHUTTER EDWARD J | AGrant, award, or other acquisition | Common Shares | 2.4K | $0.00 | Direct | May 26, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 29, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 22, 2026 | 8-K | 5.07, 9.01 | Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 30, 2026 | 8-K | 1.01, 2.03 | Material definitive agreement; New direct financial obligation | Debt | Filing |
| Feb 27, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Feb 24, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 14, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 12, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Nov 5, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Oct 3, 2025 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $67.5M | +31.7% |
| Ended Mar 31, 2026 | $59.9M | +44.7% |
| Ended Sep 30, 2025 | $53.8M | +33.7% |
| Ended Jun 30, 2025 | $51.3M | +16.3% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $211.1M | +27.1% |
| Ended Dec 31, 2024 | $166.0M | +0.5% |
| Ended Dec 31, 2023 | $165.2M | +2.1% |
| Ended Dec 31, 2022 | $161.7M | +27.6% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Initial Schedule 13G | Initial Schedule 13G | 1.6M | 12.00% | $85.81 | $91.90 | $60.61 |
| Capital Research Global Investors CIK0001422848 | Jun 30, 2025 observed Aug 13, 2025 filed · 44d Schedule 13G amendment | Reported accumulation | 28.9M +919.4K | 12.00% 0.00 pts | $42.71 | $38.34 | $60.61 |
| Capital Research Global Investors CIK0001422848 | Dec 31, 2024 observed Feb 13, 2025 filed · 44d Schedule 13G amendment | Reported accumulation | 28.0M +26.5M | 12.00% +6.70 pts | $46.07 | $33.59 | $60.61 |
Compare ESTA with other securities showing similar institutional activity or recent accumulation across several tracked institutions.